Risk of malignancy in patients treated for systemic necrotising vasculitis.
Détails
ID Serval
serval:BIB_6ABEE6226AA2
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Lettre (letter): communication adressée à l'éditeur.
Collection
Publications
Institution
Titre
Risk of malignancy in patients treated for systemic necrotising vasculitis.
Périodique
Annals of the rheumatic diseases
Collaborateur⸱rice⸱s
French Vasculitis Study Group (FVSG)
ISSN
1468-2060 (Electronic)
ISSN-L
0003-4967
Statut éditorial
Publié
Date de publication
03/2020
Peer-reviewed
Oui
Volume
79
Numéro
3
Pages
431-433
Langue
anglais
Notes
Publication types: Evaluation Study ; Letter
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Aged, Cyclophosphamide/administration & dosage, Female, Humans, Immunosuppressive Agents/administration & dosage, Male, Middle Aged, Necrosis, Neoplasms/etiology, Randomized Controlled Trials as Topic, Risk Factors, Treatment Outcome, Vasculitis/complications, Vasculitis/drug therapy, cancer, cyclophoshamide, immunosuppressive agents, rituximab, vasculitis
Pubmed
Web of science
Création de la notice
05/12/2019 23:38
Dernière modification de la notice
03/07/2020 6:26